RECRUITING

Screening for Research Participants

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will allow National Eye Institute (NEI) doctors the opportunity to examine people with eye disease, whether the diagnosis is known or not, to determine if they are eligible for other NEI research studies. No treatment is offered in this study. People of all ages with various eye conditions, including genetic conditions, eye movement disorders, inflammatory eye diseases, retinal diseases and external eye diseases, may be eligible for this study. Participants undergo various tests and procedures to diagnose or evaluate their eye disease. The procedures may include the following: * Personal and family medical history * Physical examination and blood tests, including genetic testing. * Eye examination with dilation to measure visual acuity and eye pressure and to examine the front and back parts of the eye. * Questionnaire about vision and daily activities. * Conjunctival swab or lacrimal bland biopsy, or both: A sample of cells from the eyes is collected by swabbing the surface of the eye or by surgically removing a small sample of the surface of the eye or tear gland. * Electroretinogram to examine retinal function: The subject sits in the dark with his or her eyes patched for 30 minutes. The patches are removed, the surface of the eyes is numbed, and contact lenses that can sense signals from the retina are placed on the eyes. The subject then watches flashing lights. * Fluorescein angiography to examine the blood vessels in the eye: A dye is injected into a vein in the arm. The dye travels through the veins to the blood vessels in the eyes. A camera takes pictures of the dye as it flows through the blood vessels. * Optical coherence tomography to measure retinal thickness: A machine used to examine the eyes produces cross-sectional pictures of the retina. * Microperimetry to test how sensitive different parts of the retina are to changing levels of light. The subject sits in front of a computer and presses a button when he or she sees a light on the screen. * Oculography to record eye movements: Eye movements are measured by contact lenses or goggles that the subject wears while watching a series of spots on a computer screen.

Official Title

Screening Protocol for the Evaluation and Diagnosis of Potential Research Participants

Quick Facts

Study Start:2008-08-20
Study Completion:N/A
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00655096

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:2 Years to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Have a diagnosed ocular disease/disorder; OR
  2. * Potentially have an unusual, interesting, or unknown ocular condition that requires the establishment of a diagnosis; OR
  3. * Potentially participate as a disease-free control participant in an NEI clinical research study; OR
  4. * Are an unaffected first-degree relative of a participant with either a diagnosed or undiagnosed ocular disorder; AND
  5. * Have the ability to understand and sign an informed consent OR if they are minor children have a legal parent/guardian with the ability to do the same.
  6. * Adults with impaired capacity to consent must have a Legally Authorized Representative (LAR) who is able to provide informed consent.
  1. * Are unwilling or unable to cooperate with the study procedures.
  2. * Female participants of childbearing potential who are pregnant are not eligible for enrollment.

Contacts and Locations

Study Contact

Wendy Holland, R.N.
CONTACT
(301) 435-1831
aholland@nei.nih.gov
Awilda V Holland, R.N.
CONTACT
(301) 435-1831
aholland@mail.nih.gov

Principal Investigator

Awilda V Holland, R.N.
PRINCIPAL_INVESTIGATOR
National Eye Institute (NEI)

Study Locations (Sites)

National Institutes of Health Clinical Center
Bethesda, Maryland, 20892
United States

Collaborators and Investigators

Sponsor: National Eye Institute (NEI)

  • Awilda V Holland, R.N., PRINCIPAL_INVESTIGATOR, National Eye Institute (NEI)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2008-08-20
Study Completion DateN/A

Study Record Updates

Study Start Date2008-08-20
Study Completion DateN/A

Terms related to this study

Keywords Provided by Researchers

  • Eye
  • Photograph
  • Retina

Additional Relevant MeSH Terms

  • Eye Diseases